MUCORA THERAPEUTICS LTD
Company number 13169210 · Monitor this company
Executive summary
Mucora Therapeutics Ltd is an early-stage UK-based biotech company with a strong recent capital infusion establishing a solid financial foundation for therapeutic R&D. Its strategic focus on biotechnology research positions it well for innovation-driven growth, though scaling scientific capabilities and managing funding and commercialization risks will be critical to capitalize on market opportunities. With targeted investments and partnerships, Mucora has the potential to advance promising therapeutics and enhance its competitive stance in the evolving biotech landscape.
Shareholders' funds
£1,773,563
Balance sheet as at 2026-02-28
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-02-01
- Employees
- 1 (2026 accounts)
- Registered office
- Laburnum House, East Grimstead, Salisbury, Wiltshire, United Kingdom, SP5 3RT
- Postcode
- SP5 3RT
- Capital
- 5 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2026-02-28
- Next due by
- 2027-11-30
- Financial year end
- 28 February
Confirmation statement
- Last statement dated
- 2026-02-03
- Next due by
- 2027-02-17
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current
Among its peers
Top 25%
by shareholders' funds, of 9 similar companies in SP
Trading since 2021.
Competitors Salisbury
This company ranks 2 among research and experimental development on biotechnology in Salisbury.